Palexia (Tapentadol Hydrochloride)

Tapentadol hydrochloride, the active ingredient in Palexia, is an opioid analgesic presented as a tablet for oral use. It is indicated for the management of moderate to severe acute pain in adults. GNH USA supplies Palexia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Palexia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Tapentadol hydrochloride is used in the management of pain within the nociceptive and neuropathic pathways.

- Acute postoperative pain: provides effective relief when non‑opioid analgesics are insufficient. - Chronic musculoskeletal pain: helps reduce pain intensity in conditions such as osteoarthritis. - Cancer‑related pain: contributes to overall pain control as part of a multimodal regimen. - Neuropathic pain associated with diabetic peripheral neuropathy: alleviates burning and shooting sensations. - Severe trauma pain: offers strong analgesia during the acute phase of injury.

Tapentadol may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea - Dizziness - Constipation - Headache - Somnolence - Dry mouth

Serious or Rare Side Effects: - Respiratory depression - Seizures - Severe hypotension - Serotonin syndrome - Allergic reactions (rash, angioedema) - Dependence or abuse potential

When prescribing Tapentadol, clinicians should consider several safety aspects.

- Assess pain severity: ensure the drug is appropriate for moderate to severe pain. - Review medical history: check for respiratory disorders, head injury, or substance abuse. - Monitor for sedation: advise patients about activities requiring alertness. - Avoid abrupt discontinuation: taper dose to prevent withdrawal. - Concomitant CNS depressants: use with caution due to additive effects. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Tapentadol can interact with several medication classes, requiring careful management.

Major Interactions (Avoid): - Other opioids or strong CNS depressants: risk of profound respiratory depression. - MAO inhibitors: may precipitate hypertensive crisis or serotonin syndrome. - Serotonergic agents (SSRIs, SNRIs, tramadol): increased risk of serotonin syndrome.

Moderate Interactions (Monitor Closely): - Benzodiazepines: enhanced sedation and respiratory effects. - Alcohol: additive CNS depression. - CYP2D6 inhibitors (e.g., fluoxetine): may alter tapentadol metabolism. - Antihypertensives: possible additive hypotensive effect. - Diuretics: may increase risk of orthostatic hypotension.